221 related articles for article (PubMed ID: 18303632)
21. Cost and utilization of COPD and asthma among insured adults in the US.
Blanchette CM; Broder M; Ory C; Chang E; Akazawa M; Dalal AA
Curr Med Res Opin; 2009 Jun; 25(6):1385-92. PubMed ID: 19419342
[TBL] [Abstract][Full Text] [Related]
22. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system.
Mittmann N; Kuramoto L; Seung SJ; Haddon JM; Bradley-Kennedy C; Fitzgerald JM
Respir Med; 2008 Mar; 102(3):413-21. PubMed ID: 18086519
[TBL] [Abstract][Full Text] [Related]
23. The cost of treating patients with COPD in Denmark--a population study of COPD patients compared with non-COPD controls.
Bilde L; Rud Svenning A; Dollerup J; Baekke Borgeskov H; Lange P
Respir Med; 2007 Mar; 101(3):539-46. PubMed ID: 16889949
[TBL] [Abstract][Full Text] [Related]
24. [Epidemiologic analysis of COPD in Guangdong province].
Liu SM; Wang XP; Wang DL; Zhou YM; Lü JC; Zheng JP; Zhong NS; Ran PX
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):747-52. PubMed ID: 15949380
[TBL] [Abstract][Full Text] [Related]
25. The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991.
Jacobson L; Hertzman P; Löfdahl CG; Skoogh BE; Lindgren B
Respir Med; 2000 Mar; 94(3):247-55. PubMed ID: 10783936
[TBL] [Abstract][Full Text] [Related]
26. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative.
Buist AS; Vollmer WM; McBurnie MA
Int J Tuberc Lung Dis; 2008 Jul; 12(7):703-8. PubMed ID: 18544191
[TBL] [Abstract][Full Text] [Related]
27. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
28. [Studies on direct and indirect economic burden of disease and related factor in countryside of Qingdao city in 2001].
Zhuang RS; Wang SY; Liang WN; Jing CX; Li B; Yan B
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):196-8. PubMed ID: 12816710
[TBL] [Abstract][Full Text] [Related]
29. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
[TBL] [Abstract][Full Text] [Related]
30. Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease.
Chen YH; Yao WZ; Cai BQ; Wang H; Deng XM; Gao HL; Huang JS; Wang XM
Chin Med J (Engl); 2008 Apr; 121(7):587-91. PubMed ID: 18466676
[TBL] [Abstract][Full Text] [Related]
31. [The importance of chronic obstructive pulmonary disease].
Vondra V
Vnitr Lek; 2004 Sep; 50(9):654-8. PubMed ID: 15580895
[TBL] [Abstract][Full Text] [Related]
32. Predicting the costs of managing patients with chronic obstructive pulmonary disease.
Mapel DW; McMillan GP; Frost FJ; Hurley JS; Picchi MA; Lydick E; Spencer MD
Respir Med; 2005 Oct; 99(10):1325-33. PubMed ID: 16140232
[TBL] [Abstract][Full Text] [Related]
33. Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective.
Marton JP; Boulanger L; Friedman M; Dixon D; Wilson J; Menzin J
Respir Med; 2006 Jun; 100(6):996-1005. PubMed ID: 16288858
[TBL] [Abstract][Full Text] [Related]
34. Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four cities.
Chen X; Wang N; Chen Y; Xiao T; Fu C; Xu B
Int J Chron Obstruct Pulmon Dis; 2016; 11():2625-2632. PubMed ID: 27799761
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.
Zhong N; Wang C; Yao W; Chen P; Kang J; Huang S; Chen B; Wang C; Ni D; Zhou Y; Liu S; Wang X; Wang D; Lu J; Zheng J; Ran P
Am J Respir Crit Care Med; 2007 Oct; 176(8):753-60. PubMed ID: 17575095
[TBL] [Abstract][Full Text] [Related]
36. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.
Wang G; Cheng Q; Zheng R; Tan YY; Sun XK; Zhou HY; Ye XL; Wang Y; Wang Z; Sun BM; Chen SD
Mov Disord; 2006 Sep; 21(9):1439-43. PubMed ID: 16773620
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population.
Hvidsten SC; Storesund L; Wentzel-Larsen T; Gulsvik A; Lehmann S
Clin Respir J; 2010 Jan; 4(1):13-21. PubMed ID: 20298413
[TBL] [Abstract][Full Text] [Related]
38. The COPD-induced hospitalization burden from first admission to death.
Kinnunen T; Säynäjäkangas O; Keistinen T
Respir Med; 2007 Feb; 101(2):294-9. PubMed ID: 16774818
[TBL] [Abstract][Full Text] [Related]
39. Changes in COPD demographics and costs over 20 years.
Blanchette CM; Dalal AA; Mapel D
J Med Econ; 2012; 15(6):1176-82. PubMed ID: 22812689
[TBL] [Abstract][Full Text] [Related]
40. [Estimation of direct medical costs of chronic obstructive pulmonary disease over 12 months].
Stâmbu I; Stoicescu IP
Pneumologia; 2013; 62(2):86-92. PubMed ID: 23894789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
